Clinical trial
First-in-Human Dose Escalation Trial in Subjects With Advanced Malignancies
NCT01971515
Study timeline
Study start (actual)2013-12-13Date precision: day
Registry last updated2018-09-19
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Solid Tumorunresolved
Interventions
Sponsors & collaborators
EMD Seronolead sponsor
Mapped research locations
DetroitMichigan, United States2New YorkNew York, United States1HoustonTexas, United States1BostonMassachusetts, United States1Los AngelesCalifornia, United States1DallasTexas, United States1St LouisMissouri, United States1MiamiFlorida, United States1San AntonioTexas, United States1BirminghamAlabama, United States1San DiegoCalifornia, United States1CharlestonSouth Carolina, United States1
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT01971515 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.